Identification of a conserved S2 epitope present on spike proteins from all highly pathogenic coronaviruses

鉴定所有高致病性冠状病毒刺突蛋白上存在的保守S2表位

阅读:4
作者:Rui P Silva # ,Yimin Huang # ,Annalee W Nguyen # ,Ching-Lin Hsieh ,Oladimeji S Olaluwoye ,Tamer S Kaoud ,Rebecca E Wilen ,Ahlam N Qerqez ,Jun-Gyu Park ,Ahmed M Khalil ,Laura R Azouz ,Kevin C Le ,Amanda L Bohanon ,Andrea M DiVenere ,Yutong Liu ,Alison G Lee ,Dzifa A Amengor ,Sophie R Shoemaker ,Shawn M Costello ,Eduardo A Padlan ,Susan Marqusee ,Luis Martinez-Sobrido ,Kevin N Dalby ,Sheena D'Arcy ,Jason S McLellan ,Jennifer A Maynard

Abstract

To address the ongoing SARS-CoV-2 pandemic and prepare for future coronavirus outbreaks, understanding the protective potential of epitopes conserved across SARS-CoV-2 variants and coronavirus lineages is essential. We describe a highly conserved, conformational S2 domain epitope present only in the prefusion core of β-coronaviruses: SARS-CoV-2 S2 apex residues 980-1006 in the flexible hinge. Antibody RAY53 binds the native hinge in MERS-CoV and SARS-CoV-2 spikes on the surface of mammalian cells and mediates antibody-dependent cellular phagocytosis and cytotoxicity against SARS-CoV-2 spike in vitro. Hinge epitope mutations that ablate antibody binding compromise pseudovirus infectivity, but changes elsewhere that affect spike opening dynamics, including those found in Omicron BA.1, occlude the epitope and may evade pre-existing serum antibodies targeting the S2 core. This work defines a third class of S2 antibody while providing insights into the potency and limitations of S2 core epitope targeting.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。